<\/p>\n
The stock\u2019s positive momentum follows a report that highlighted AMC\u2019s record revenue and EBITDA, showcasing its resilience in the post-COVID landscape as moviegoers return to theaters in droves.<\/p>\n
<\/p>\n <\/p>\n AMC announced its highest quarterly revenue in company history, driven by a strong lineup of films <\/a>and robust food and beverage sales.<\/p>\n <\/p>\n The largest cinema chain operator\u2019s revenue rose 14.2% year over year (Y\/Y) to $1.60 billion, exceeding estimates of $1.47 billion. This is supported by higher attendance, box office growth, and increased per-guest spending.<\/p>\n <\/p>\n Adjusted EPS of 14 cents surpassed the analyst expectations for a loss of six cents per share.<\/p>\n <\/p>\n Adjusted EBITDA rose 70% to a\u00a0record $321.4 million<\/a>, surpassing $300 million for the first time and improving $131.9 million from the prior-year quarter.<\/p>\n <\/p>\n CEO Adam Aron emphasized the company\u2019s success in attracting audiences back <\/a>to theaters, declaring victory over the competition from at-home viewing options.<\/p>\n <\/p>\n “We\u2019re within sight of being cash flow positive, not for a quarter, but for a year,” Aron said during the earnings call. He later acknowledged the company is “not quite at the promised land yet\u2026 but we\u2019re ever so close.”<\/p>\n <\/p>\n <\/p>\n Management expects 2026 to be the strongest post-pandemic year for both domestic and global box office performance.<\/p>\n <\/p>\n <\/p>\n The stock is currently trading at $2.46, which is approximately 36% above its 200-day simple moving average (SMA) of $1.82. The moving average convergence divergence (MACD) is above its signal line, indicating that downside pressure is easing and momentum is improving compared to the prior downswing.<\/p>\n <\/p>\n AMC\u2019s 12-month performance shows a decline of about 28.49%, but recent price action has been more favorable, with the stock trading significantly above its 20-day SMA of $2.01 and 50-day SMA of $1.88. The recent golden cross in July, where the 50-day SMA crossed above the 200-day SMA, further supports the bullish sentiment.<\/p>\n <\/p>\n Key Resistance<\/strong>: $3.60 \u2014 This level marks the 52-week high, indicating strong selling interest may emerge here. Key Support<\/strong>: $1.88 \u2014 This level aligns with the 50-day SMA, providing a potential floor for price action.<\/p>\n <\/p>\n <\/p>\n Analyst Consensus & Recent Actions:<\/strong> The stock carries a Hold rating with an average price forecast<\/a> of $1.80. Recent analyst moves include:<\/p>\n <\/p>\n <\/p>\nResults Drive Record Revenue And EBITDA<\/h2>\n
Outlook<\/h2>\n
AMC Technical Outlook: Momentum Improves Above Key Averages<\/h2>\n
AMC Analyst Ratings<\/h2>\n
\n